Risk stratification: a tool to predict the course of active surveillance for localized prostate cancer?

Jan HerdenAxel HeidenreichLothar Weissbach

Published in: BJU international (2016)

Our results show no differences in the outcome of risk-stratified patients in the specified risk groups managed with AS, while switching to an invasive treatment on the patient's request was more frequent in the intermediate-/high-risk group.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
radical prostatectomy
peritoneal dialysis
patient reported outcomes